Biomarkers to stratify risk groups among children with malnutrition in resource-limited settings and to monitor response to intervention

Hormone Research in Paediatrics

Volumn 88, Issue 1, 2017, Pages 111-117

  McGrath, Christine J ^a   Arndt, Michael B ^b   Walson, Judd L ^c,d,e  

^a University of Texas Medical Branch School of Medicine   (United States)

^b PATH   (United States)

^c UNIVERSITY OF WASHINGTON   (United States)

^d UNIVERSITY OF WASHINGTON SCHOOL OF MEDICINE   (United States)

^e The Childhood Acute Illness and Nutrition Network (CHAIN)   (Kenya)

Author keywords

Environmental enteric dysfunction; Growth; Gut microbiome; Inflammation; Malnutrition; Stunting

Indexed keywords

ALPHA 1 ANTITRYPSIN; BIOLOGICAL MARKER; FIBROBLAST GROWTH FACTOR 21; GROWTH HORMONE; KYNURENINE; LACTULOSE; MANNITOL; RHAMNOSE; RNA 16S;

ACIDAMINOCOCCUS; BONE METABOLISM; ENTEROPATHY; FECES MICROFLORA; HIGH RISK POPULATION; HORMONE RESISTANCE; HUMAN; INFLAMMATION; INTESTINE FLORA; INTESTINE MUCOSA PERMEABILITY; INTESTINE VILLUS ATROPHY; MALABSORPTION; MALNUTRITION; MICROBIAL COMMUNITY; MORBIDITY; MORTALITY RISK; NONHUMAN; PRIORITY JOURNAL; REVIEW; STUNTING; CHILD; COMPLICATION; GROWTH DISORDER; PATHOPHYSIOLOGY; RISK ASSESSMENT;

BIOMARKERS; CHILD; GASTROINTESTINAL MICROBIOME; GROWTH DISORDERS; HUMANS; INFLAMMATION; MALNUTRITION; RISK ASSESSMENT;

EID: 85018893405     PISSN: 16632818     EISSN: 16632826     Source Type: Journal    
DOI: 10.1159/000471875     Document Type: Review

References (54)

1. Black RE, Victora CG, Walker SP, Bhutta ZA, Christian P, de Onis M, et al: Maternal and child undernutrition and overweight in low-income and middle-income countries. Lancet 2013;382: 427-451.
2. UNICEF-WHO-World Bank Group: Joint Child Malnutrition Estimates-Levels and Trends. 2016. http://www.who.int/nutgrowthdb/estimates2015/en/.
3. Olofin I, McDonald CM, Ezzati M, Flaxman S, Black RE, Fawzi WW, et al: Associations of suboptimal growth with all-cause and cause-specific mortality in children under five years: a pooled analysis of ten prospective studies. PLoS One 2013;8:e64636.
4. Victora CG, Adair L, Fall C, Hallal PC, Martorell R, Richter L, et al: Maternal and child undernutrition: consequences for adult health and human capital. Lancet 2008;371: 340-357.
5. Grantham-McGregor S, Cheung YB, Cueto S, Glewwe P, Richter L, Strupp B, et al: Developmental potential in the first 5 years for children in developing countries. Lancet 2007;369: 60-70.
6. Guerrant RL, DeBoer MD, Moore SR, Scharf RJ, Lima AA: The impoverished gut-a triple burden of diarrhoea, stunting and chronic disease. Nat Rev Gastroenterol Hepatol 2013;10: 220-229.
7. Salam RA, MacPhail C, Das JK, Bhutta ZA: Effectiveness of micronutrient powders (MNP) in women and children. BMC Public Health 2013;13(suppl 3):S22.
8. Bhutta ZA, Das JK, Rizvi A, Gaffey MF, Walker N, Horton S, et al: Evidence-based interventions for improvement of maternal and child nutrition: what can be done and at what cost? Lancet 2013;382: 452-477.
9. Dewey KG, Adu-Afarwuah S: Systematic review of the efficacy and effectiveness of complementary feeding interventions in developing countries. Matern Child Nutr 2008;4(suppl 1):24-85.
10. Keusch GT, Denno DM, Black RE, Duggan C, Guerrant RL, Lavery JV, et al: Environmental enteric dysfunction: pathogenesis, diagnosis, and clinical consequences. Clin Infect Dis 2014;59(suppl 4):S207-S212.
11. Brown EM, Wlodarska M, Willing BP, Vonaesch P, Han J, Reynolds LA, et al: Diet and specific microbial exposure trigger features of environmental enteropathy in a novel murine model. Nat Commun 2015;6: 7806.
12. Tickell KD, Walson JL: Nutritional enteric failure: neglected tropical diseases and childhood stunting. PLoS Negl Trop Dis 2016;10:e0004523.
13. Gordon JI, Dewey KG, Mills DA, Medzhitov RM: The human gut microbiota and undernutrition. Sci Transl Med 2012;4: 137ps112.
14. Prendergast A, Kelly P: Enteropathies in the developing world: neglected effects on global health. Am J Trop Med Hyg 2012;86: 756-763.
15. Humphrey JH: Child undernutrition, tropical enteropathy, toilets, and handwashing. Lancet 2009;374: 1032-1035.
16. Bourke CD, Berkley JA, Prendergast AJ: Immune dysfunction as a cause and consequence of malnutrition. Trends Immunol 2016;37: 386-398.
17. Korpe PS, Petri WA Jr: Environmental enteropathy: critical implications of a poorly understood condition. Trends Mol Med 2012;18: 328-336.
18. Watanabe K, Petri WA Jr: Environmental enteropathy: elusive but significant subclinical abnormalities in developing countries. EBioMedicine 2016;10: 25-32.
19. Schwarzer M, Makki K, Storelli G, Machuca-Gayet I, Srutkova D, Hermanova P, et al: Lactobacillus plantarum strain maintains growth of infant mice during chronic undernutrition. Science 2016;351: 854-857.
20. Fazeli PK, Klibanski A: Determinants of GH resistance in malnutrition. J Endocrinol 2014;220:R57-R65.
21. Veitch AM, Kelly P, Zulu IS, Segal I, Farthing MJ: Tropical enteropathy: a T-cell-mediated crypt hyperplastic enteropathy. Eur J Gastroenterol Hepatol 2001;13: 1175-1181.
22. Lunn PG, Northrop-Clewes CA, Downes RM: Intestinal permeability, mucosal injury, and growth faltering in Gambian infants. Lancet 1991;338: 907-910.
23. Faubion W, Camilleri M, Murray J, Kelly P, Amadi B, Kosek M, et al: Improving the detection of environmental enteric dysfunction: a lactulose, rhamnose assay of intestinal permeability in children aged 5 years exposed to poor sanitation and hygiene. BMJ Global Health 2016;1:e000066.
24. Brewster DR, Manary MJ, Menzies IS, O'Loughlin EV, Henry RL: Intestinal permeability in kwashiorkor. Arch Dis Child 1997;76: 236-241.
25. Denno DM, VanBuskirk K, Nelson ZC, Musser CA, Hay Burgess DC, Tarr PI: Use of the lactulose to mannitol ratio to evaluate childhood environmental enteric dysfunction: a systematic review. Clin Infect Dis 2014;59(suppl 4):S213-S219.
26. Guerrant RL, Leite AM, Pinkerton R, Medeiros PH, Cavalcante PA, DeBoer M, et al: Biomarkers of environmental enteropathy, inflammation, stunting, and impaired growth in children in northeast Brazil. PLoS One 2016;11:e0158772.
27. Tigas S, Tsatsoulis A: Endocrine and metabolic manifestations in inflammatory bowel disease. Ann Gastroenterol 2012;25: 37-44.
28. Prendergast AJ, Rukobo S, Chasekwa B, Mutasa K, Ntozini R, Mbuya MN, et al: Stunting is characterized by chronic inflammation in Zimbabwean infants. PLoS One 2014;9: e86928.
29. Kosek M, Haque R, Lima A, Babji S, Shrestha S, Qureshi S, et al: Fecal markers of intestinal inflammation and permeability associated with the subsequent acquisition of linear growth deficits in infants. Am J Trop Med Hyg 2013;88: 390-396.
30. Naylor C, Lu M, Haque R, Mondal D, Buonomo E, Nayak U, et al: Environmental enteropathy, oral vaccine failure and growth faltering in infants in Bangladesh. EBioMedicine 2015;2: 1759-1766.
31. Peterson KM, Buss J, Easley R, Yang Z, Korpe PS, Niu F, et al: REG1B as a predictor of childhood stunting in Bangladesh and Peru. Am J Clin Nutr 2013;97: 1129-1133.
32. Campbell DI, Elia M, Lunn PG: Growth faltering in rural Gambian infants is associated with impaired small intestinal barrier function, leading to endotoxemia and systemic inflammation. J Nutr 2003;133: 1332-1338.
33. Kosek MN, Mduma E, Kosek PS, Lee GO, Svensen E, Pan WK, et al: Plasma tryptophan and the kynurenine-tryptophan ratio are associated with the acquisition of statural growth deficits and oral vaccine underperformance in populations with environmental enteropathy. Am J Trop Med Hyg 2016;95: 928-937.
34. Mericq V, De Luca F, Hernandez MI, Pena V, Rossel K, Garcia M, et al: Serum fibroblast growth factor 21 levels are inversely associated with growth rates in infancy. Horm Res Paediatr 2014;82: 324-331.
35. Inagaki T, Lin VY, Goetz R, Mohammadi M, Mangelsdorf DJ, Kliewer SA: Inhibition of growth hormone signaling by the fasting-induced hormone FGF21. Cell Metab 2008;8: 77-83.
36. Wu S, Levenson A, Kharitonenkov A, De Luca F: Fibroblast growth factor 21 (FGF21) inhibits chondrocyte function and growth hormone action directly at the growth plate. J Biol Chem 2012;287: 26060-26067.
37. Kubicky RA, Wu S, Kharitonenkov A, De Luca F: Role of fibroblast growth factor 21 (FGF21) in undernutrition-related attenuation of growth in mice. Endocrinology 2012;153: 2287-2295.
38. Arndt MB, Mahfuz M, Ahmed T, Haque R, Gazi MA, John-Stewart GC, Denno DM, Richardson BA, Scarlett JM, Walson JL: Fibroblast growth factor 21 as a biomarker of nutrition responsiveness. Poster presented at the 3rd International Conference on Nutrition & Growth, March 17-19, 2016, Vienna, Austria. Abstract No. NGC16-0490.
39. Rodriguez JM, Murphy K, Stanton C, Ross RP, Kober OI, Juge N, et al: The composition of the gut microbiota throughout life, with an emphasis on early life. Microb Ecol Health Dis 2015;26: 26050.
40. Planer JD, Peng Y, Kau AL, Blanton LV, Ndao IM, Tarr PI, et al: Development of the gut microbiota and mucosal IgA responses in twins and gnotobiotic mice. Nature 2016;534: 263-266.
41. Kau AL, Ahern PP, Griffin NW, Goodman AL, Gordon JI: Human nutrition, the gut microbiome and the immune system. Nature 2011;474: 327-336.
42. Subramanian S, Blanton LV, Frese SA, Charbonneau M, Mills DA, Gordon JI: Cultivating healthy growth and nutrition through the gut microbiota. Cell 2015;161: 36-48.
43. Subramanian S, Huq S, Yatsunenko T, Haque R, Mahfuz M, Alam MA, et al: Persistent gut microbiota immaturity in malnourished Bangladeshi children. Nature 2014;510: 417-421.
44. Smith MI, Yatsunenko T, Manary MJ, Trehan I, Mkakosya R, Cheng J, et al: Gut microbiomes of Malawian twin pairs discordant for kwashiorkor. Science 2013;339: 548-554.
45. Gough EK, Stephens DA, Moodie EE, Prendergast AJ, Stoltzfus RJ, Humphrey JH, et al: Linear growth faltering in infants is associated with Acidaminococcus sp. and community-level changes in the gut microbiota. Microbiome 2015;3: 24.
46. Blanton LV, Charbonneau MR, Salih T, Barratt MJ, Venkatesh S, Ilkaveya O, et al: Gut bacteria that prevent growth impairments transmitted by microbiota from malnourished children. Science 2016;351.
47. Ohlsson C, Sjogren K: Effects of the gut microbiota on bone mass. Trends Endocrinol Metab 2015;26: 69-74.
48. Blanton LV, Barratt MJ, Charbonneau MR, Ahmed T, Gordon JI: Childhood undernutrition, the gut microbiota, and microbiota-directed therapeutics. Science 2016;352: 1533.
49. De Benedetti F, Alonzi T, Moretta A, Lazzaro D, Costa P, Poli V, et al: Interleukin 6 causes growth impairment in transgenic mice through a decrease in insulin-like growth factor-I. A model for stunted growth in children with chronic inflammation. J Clin Invest 1997;99: 643-650.
50. Azad MB, Konya T, Maughan H, Guttman DS, Field CJ, Sears MR, et al: Infant gut microbiota and the hygiene hypothesis of allergic disease: impact of household pets and siblings on microbiota composition and diversity. Allergy Asthma Clin Immunol 2013;9: 15.
51. Donowitz JR, Haque R, Kirkpatrick BD, Alam M, Lu M, Kabir M, et al: Small intestine bacterial overgrowth and environmental enteropathy in Bangladeshi children. MBio 2016;7: e02102-15.
52. Charbonneau MR, O'Donnell D, Blanton LV, Totten SM, Davis JC, Barratt MJ, et al: Sialylated milk oligosaccharides promote microbiota-dependent growth in models of infant undernutrition. Cell 2016;164: 859-871.
53. Kelly CR, Kahn S, Kashyap P, Laine L, Rubin D, Atreja A, et al: Update on fecal microbiota transplantation 2015: indications, methodologies, mechanisms, and outlook. Gastroenterology 2015;149: 223-237.
54. Petrof EO, Gloor GB, Vanner SJ, Weese SJ, Carter D, Daigneault MC, et al: Stool substitute transplant therapy for the eradication of Clostridium difficile infection: 'RePOOPulating' the gut. Microbiome 2013; 1: 3.